{
      "Rank": 211,
      "Acronym": [],
      "AgreementOtherDetails": [],
      "AgreementPISponsorEmployee": [],
      "AgreementRestrictionType": [],
      "AgreementRestrictiveAgreement": [],
      "ArmGroupDescription": [
            "The dose of adipose-derived mesenchymal stem cells was related to body weight, and 1 \u00d7 10 ^ 6 cells were a unit. One unit of adipose-derived mesenchymal stem cells was injected every 10 kg of body weight and injected once a week for three times.",
            "1ml dexamethasone mixed with 0.5-2ml of saline to achieve the same injection volume with the cell suspension (which contains betamethasone dipropionate 5mg and betamethasone sodium phosphate 2mg) ), once a week for three times."
      ],
      "ArmGroupInterventionName": [
            "Biological: Autologous adipose-derived MSCs",
            "Drug: Compound betamethasone"
      ],
      "ArmGroupLabel": [
            "Autologous adipose-derived MSCs",
            "Compound betamethasone"
      ],
      "ArmGroupType": [
            "Experimental",
            "Active Comparator"
      ],
      "AvailIPDComment": [],
      "AvailIPDId": [],
      "AvailIPDType": [],
      "AvailIPDURL": [],
      "BaselineCategoryTitle": [],
      "BaselineClassDenomCountGroupId": [],
      "NCTId": [
            "NCT03279796"
      ],
      "BaselineClassDenomCountValue": [],
      "BaselineClassDenomUnits": [],
      "BaselineClassTitle": [],
      "BaselineDenomCountGroupId": [],
      "BaselineDenomCountValue": [],
      "BaselineDenomUnits": [],
      "BaselineGroupDescription": [],
      "BaselineGroupId": [],
      "BaselineGroupTitle": [],
      "BaselineMeasureCalculatePct": [],
      "BaselineMeasureDenomCountGroupId": [],
      "BaselineMeasureDenomCountValue": [],
      "BaselineMeasureDenomUnits": [],
      "BaselineMeasureDenomUnitsSelected": [],
      "BaselineMeasureDescription": [],
      "BaselineMeasureDispersionType": [],
      "BaselineMeasureParamType": [],
      "BaselineMeasurePopulationDescription": [],
      "BaselineMeasureTitle": [],
      "BaselineMeasureUnitOfMeasure": [],
      "BaselineMeasurementComment": [],
      "BaselineMeasurementGroupId": [],
      "BaselineMeasurementLowerLimit": [],
      "BaselineMeasurementSpread": [],
      "BaselineMeasurementUpperLimit": [],
      "BaselineMeasurementValue": [],
      "BaselinePopulationDescription": [],
      "BaselineTypeUnitsAnalyzed": [],
      "BioSpecDescription": [],
      "BioSpecRetention": [],
      "BriefSummary": [
            "This study was a single-center, randomized, single-blind clinical trial. We plan to include 100 patients who met exclusion criteria of rotator cuff and lateral epicondylosis (tennis elbow) respectively by MRT or ultrasonography. The patients will be randomly divided into two groups. Adipose mesenchymal stem cells will be isolated from adipose tissue, cultured and then transplanted back to the tendon injury site by multiple point injection. 1*10^6 cells as an unit. Patients in the experiment group will be injected into an unit of adipose mesenchymal stem cells (1*10^6/10kg) while the control group received the same dose compound betamethasone injection. Follow up visit for all patients will occur at 1\uff0c3\uff0c6 and 12 months after the first injection. Clinical quantitative assessment will measure by the visual analogue scale(VAS). The secondary outcomes are the constant-murley score(CMS) and the rating scale of the American shoulder and elbow surgeons(ASES) and the disability of arm shoulder and hand(DASH). The objective evaluation methods is that the examination of MRI or ultrasound were accomplished before the first injection and at 6 and 12 months afterwards."
      ],
      "BriefTitle": [
            "Treatment of Tendon Disease Using Autologous Adipose-derived Mesenchymal Stem Cells"
      ],
      "CentralContactEMail": [
            "wlshen@zju.edu.cn"
      ],
      "CentralContactName": [
            "Weiliang Shen, Doctor"
      ],
      "CentralContactPhone": [
            "+86-13757101563"
      ],
      "CentralContactPhoneExt": [],
      "CentralContactRole": [
            "Contact"
      ],
      "CollaboratorClass": [
            "INDUSTRY"
      ],
      "CollaboratorName": [
            "Zhejiang Xingyue Biotechnology Co., Ltd."
      ],
      "CompletionDate": [
            "December 31, 2021"
      ],
      "CompletionDateType": [
            "Anticipated"
      ],
      "Condition": [
            "Rotator Cuff Tear",
            "Lateral Epicondylitis"
      ],
      "ConditionAncestorId": [
            "D000012421",
            "D000014947",
            "D000070599",
            "D000013708",
            "D000070639",
            "D000052256",
            "D000009135",
            "D000009140",
            "D000001134"
      ],
      "ConditionAncestorTerm": [
            "Rupture",
            "Wounds and Injuries",
            "Shoulder Injuries",
            "Tendon Injuries",
            "Elbow Tendinopathy",
            "Tendinopathy",
            "Muscular Diseases",
            "Musculoskeletal Diseases",
            "Arm Injuries"
      ],
      "ConditionBrowseBranchAbbrev": [
            "BC26",
            "All",
            "BC05",
            "BC10"
      ],
      "ConditionBrowseBranchName": [
            "Wounds and Injuries",
            "All Conditions",
            "Musculoskeletal Diseases",
            "Nervous System Diseases"
      ],
      "ConditionBrowseLeafAsFound": [
            "Rotator Cuff Tear",
            "Lateral Epicondylitis"
      ],
      "ConditionBrowseLeafId": [
            "M14393",
            "M624",
            "M15638",
            "M21938",
            "M16837",
            "M602",
            "M15631",
            "M26166",
            "M627",
            "M11244",
            "M11249",
            "M3596"
      ],
      "ConditionBrowseLeafName": [
            "Rupture",
            "Rotator Cuff Injuries",
            "Tennis Elbow",
            "Lacerations",
            "Wounds and Injuries",
            "Shoulder Injuries",
            "Tendon Injuries",
            "Tendinopathy",
            "Elbow Tendinopathy",
            "Muscular Diseases",
            "Musculoskeletal Diseases",
            "Arm Injuries"
      ],
      "ConditionBrowseLeafRelevance": [
            "low",
            "high",
            "high",
            "low",
            "low",
            "low",
            "low",
            "low",
            "low",
            "low",
            "low",
            "low"
      ],
      "ConditionMeshId": [
            "D000013716",
            "D000070636"
      ],
      "ConditionMeshTerm": [
            "Tennis Elbow",
            "Rotator Cuff Injuries"
      ],
      "DelayedPosting": [],
      "DesignAllocation": [
            "Randomized"
      ],
      "DesignInterventionModel": [
            "Parallel Assignment"
      ],
      "DesignInterventionModelDescription": [],
      "DesignMasking": [
            "Single"
      ],
      "DesignMaskingDescription": [],
      "DesignObservationalModel": [],
      "DesignPrimaryPurpose": [
            "Treatment"
      ],
      "DesignTimePerspective": [],
      "DesignWhoMasked": [
            "Participant"
      ],
      "DetailedDescription": [
            "All injection will be done under ultrasound guidance."
      ],
      "DispFirstPostDate": [],
      "DispFirstPostDateType": [],
      "DispFirstSubmitDate": [],
      "DispFirstSubmitQCDate": [],
      "EligibilityCriteria": [
            "Inclusion Criteria:\n\nclinically diagnosed as rotator cuff tear or lateral epicondylitis (tennis elbow);\nsymptom duration is over 3 months, non-steroidal drug treatment , rehabilitation treatment and other conservative treatment is invalid;\npatient that can understand the clinical trials and signed the informed consent.\n\nExclusion Criteria:\n\npatient that underwent other injection treatment within 6 weeks\nsome associated diseases (such as arthritis, synovitis, entrapment of related nerve, radiculopathy to the target lesion, generalized pain syndrome, rheumatoid arthritis, pregnancy, impaired sensibility, paralysis, history of allergic or hypersensitive reaction to bovine-derived proteins or fibrin glue)\npatient that enrolled other clinical trials within 3 months\nhistory of drug/alcohol addiction, habitual smoker"
      ],
      "EnrollmentCount": [
            "200"
      ],
      "EnrollmentType": [
            "Anticipated"
      ],
      "EventGroupDeathsNumAffected": [],
      "EventGroupDeathsNumAtRisk": [],
      "EventGroupDescription": [],
      "EventGroupId": [],
      "EventGroupOtherNumAffected": [],
      "EventGroupOtherNumAtRisk": [],
      "EventGroupSeriousNumAffected": [],
      "EventGroupSeriousNumAtRisk": [],
      "EventGroupTitle": [],
      "EventsDescription": [],
      "EventsFrequencyThreshold": [],
      "EventsTimeFrame": [],
      "ExpAccTypeIndividual": [],
      "ExpAccTypeIntermediate": [],
      "ExpAccTypeTreatment": [],
      "ExpandedAccessNCTId": [],
      "ExpandedAccessStatusForNCTId": [],
      "FDAAA801Violation": [],
      "FlowAchievementComment": [],
      "FlowAchievementGroupId": [],
      "FlowAchievementNumSubjects": [],
      "FlowAchievementNumUnits": [],
      "FlowDropWithdrawComment": [],
      "FlowDropWithdrawType": [],
      "FlowGroupDescription": [],
      "FlowGroupId": [],
      "FlowGroupTitle": [],
      "FlowMilestoneComment": [],
      "FlowMilestoneType": [],
      "FlowPeriodTitle": [],
      "FlowPreAssignmentDetails": [],
      "FlowReasonComment": [],
      "FlowReasonGroupId": [],
      "FlowReasonNumSubjects": [],
      "FlowReasonNumUnits": [],
      "FlowRecruitmentDetails": [],
      "FlowTypeUnitsAnalyzed": [],
      "Gender": [
            "All"
      ],
      "GenderBased": [],
      "GenderDescription": [],
      "HasExpandedAccess": [
            "No"
      ],
      "HealthyVolunteers": [
            "No"
      ],
      "IPDSharing": [
            "No"
      ],
      "IPDSharingAccessCriteria": [],
      "IPDSharingDescription": [],
      "IPDSharingInfoType": [],
      "IPDSharingTimeFrame": [],
      "IPDSharingURL": [],
      "InterventionAncestorId": [
            "D000000893",
            "D000005938",
            "D000006728",
            "D000006730",
            "D000045505",
            "D000018927",
            "D000019141"
      ],
      "InterventionAncestorTerm": [
            "Anti-Inflammatory Agents",
            "Glucocorticoids",
            "Hormones",
            "Hormones, Hormone Substitutes, and Hormone Antagonists",
            "Physiological Effects of Drugs",
            "Anti-Asthmatic Agents",
            "Respiratory System Agents"
      ],
      "InterventionArmGroupLabel": [
            "Autologous adipose-derived MSCs",
            "Compound betamethasone"
      ],
      "InterventionBrowseBranchAbbrev": [
            "Infl",
            "ANeo",
            "AnEm",
            "Gast",
            "All",
            "Resp"
      ],
      "InterventionBrowseBranchName": [
            "Anti-Inflammatory Agents",
            "Antineoplastic Agents",
            "Antiemetics",
            "Gastrointestinal Agents",
            "All Drugs and Chemicals",
            "Respiratory System Agents"
      ],
      "InterventionBrowseLeafAsFound": [
            "At 3"
      ],
      "InterventionBrowseLeafId": [
            "M6254",
            "M235540",
            "M4061",
            "M4062",
            "M229281",
            "M259082",
            "M248671",
            "M3369",
            "M8199",
            "M8941",
            "M8940",
            "M20116",
            "M20290"
      ],
      "InterventionBrowseLeafName": [
            "Dexamethasone",
            "Dexamethasone acetate",
            "Betamethasone",
            "Betamethasone Valerate",
            "Betamethasone-17,21-dipropionate",
            "Betamethasone benzoate",
            "Betamethasone sodium phosphate",
            "Anti-Inflammatory Agents",
            "Glucocorticoids",
            "Hormones",
            "Hormone Antagonists",
            "Anti-Asthmatic Agents",
            "Respiratory System Agents"
      ],
      "InterventionBrowseLeafRelevance": [
            "low",
            "low",
            "high",
            "low",
            "low",
            "low",
            "low",
            "low",
            "low",
            "low",
            "low",
            "low",
            "low"
      ],
      "InterventionDescription": [
            "The dose of adipose-derived mesenchymal stem cells was related to body weight, and 1 \u00d7 10 ^ 6 cells were a unit. One unit of adipose-derived mesenchymal stem cells was injected every 10 kg of body weight and injected once a week for three times.",
            "1ml dexamethasone mixed with 0.5-2ml of saline to achieve the same injection volume with the cell suspension (which contains betamethasone dipropionate 5mg and betamethasone sodium phosphate 2mg) ), once a week for three times."
      ],
      "InterventionMeshId": [
            "D000001623"
      ],
      "InterventionMeshTerm": [
            "Betamethasone"
      ],
      "InterventionName": [
            "Autologous adipose-derived MSCs",
            "Compound betamethasone"
      ],
      "InterventionOtherName": [],
      "InterventionType": [
            "Biological",
            "Drug"
      ],
      "IsFDARegulatedDevice": [
            "No"
      ],
      "IsFDARegulatedDrug": [
            "No"
      ],
      "IsPPSD": [],
      "IsUSExport": [],
      "IsUnapprovedDevice": [],
      "Keyword": [
            "Adipose-drived mesenchymal stem cells",
            "Rotator cuff injury",
            "Lateral Epicondylitis",
            "Randomized controlled trials"
      ],
      "LargeDocDate": [],
      "LargeDocFilename": [],
      "LargeDocHasICF": [],
      "LargeDocHasProtocol": [],
      "LargeDocHasSAP": [],
      "LargeDocLabel": [],
      "LargeDocTypeAbbrev": [],
      "LargeDocUploadDate": [],
      "LastKnownStatus": [
            "Not yet recruiting"
      ],
      "LastUpdatePostDate": [
            "April 26, 2018"
      ],
      "LastUpdatePostDateType": [
            "Actual"
      ],
      "LastUpdateSubmitDate": [
            "April 24, 2018"
      ],
      "LeadSponsorClass": [
            "OTHER"
      ],
      "LeadSponsorName": [
            "Second Affiliated Hospital, School of Medicine, Zhejiang University"
      ],
      "LimitationsAndCaveatsDescription": [],
      "LocationCity": [
            "Hangzhou"
      ],
      "LocationContactEMail": [],
      "LocationContactName": [
            "Weiliang Shen, Doctor"
      ],
      "LocationContactPhone": [],
      "LocationContactPhoneExt": [],
      "LocationContactRole": [
            "Contact"
      ],
      "LocationCountry": [
            "China"
      ],
      "LocationFacility": [
            "Weiliang Shen"
      ],
      "LocationState": [
            "Zhejiang"
      ],
      "LocationStatus": [],
      "LocationZip": [
            "310058"
      ],
      "MaximumAge": [
            "90 Years"
      ],
      "MinimumAge": [
            "18 Years"
      ],
      "NCTIdAlias": [],
      "OfficialTitle": [
            "Autologous Adipose-derived Mesenchymal Stem Cells in the Treatment of Tendon Disease: a Randomized Controlled Trial"
      ],
      "OrgClass": [
            "OTHER"
      ],
      "OrgFullName": [
            "Second Affiliated Hospital, School of Medicine, Zhejiang University"
      ],
      "OrgStudyId": [
            "2017.No.55"
      ],
      "OrgStudyIdDomain": [],
      "OrgStudyIdLink": [],
      "OrgStudyIdType": [],
      "OtherEventAssessmentType": [],
      "OtherEventNotes": [],
      "OtherEventOrganSystem": [],
      "OtherEventSourceVocabulary": [],
      "OtherEventStatsGroupId": [],
      "OtherEventStatsNumAffected": [],
      "OtherEventStatsNumAtRisk": [],
      "OtherEventStatsNumEvents": [],
      "OtherEventTerm": [],
      "OtherOutcomeDescription": [],
      "OtherOutcomeMeasure": [],
      "OtherOutcomeTimeFrame": [],
      "OutcomeAnalysisCILowerLimit": [],
      "OutcomeAnalysisCILowerLimitComment": [],
      "OutcomeAnalysisCINumSides": [],
      "OutcomeAnalysisCIPctValue": [],
      "OutcomeAnalysisCIUpperLimit": [],
      "OutcomeAnalysisCIUpperLimitComment": [],
      "OutcomeAnalysisDispersionType": [],
      "OutcomeAnalysisDispersionValue": [],
      "OutcomeAnalysisEstimateComment": [],
      "OutcomeAnalysisGroupDescription": [],
      "OutcomeAnalysisGroupId": [],
      "OutcomeAnalysisNonInferiorityComment": [],
      "OutcomeAnalysisNonInferiorityType": [],
      "OutcomeAnalysisOtherAnalysisDescription": [],
      "OutcomeAnalysisPValue": [],
      "OutcomeAnalysisPValueComment": [],
      "OutcomeAnalysisParamType": [],
      "OutcomeAnalysisParamValue": [],
      "OutcomeAnalysisStatisticalComment": [],
      "OutcomeAnalysisStatisticalMethod": [],
      "OutcomeAnalysisTestedNonInferiority": [],
      "OutcomeCategoryTitle": [],
      "OutcomeClassDenomCountGroupId": [],
      "OutcomeClassDenomCountValue": [],
      "OutcomeClassDenomUnits": [],
      "OutcomeClassTitle": [],
      "OutcomeDenomCountGroupId": [],
      "OutcomeDenomCountValue": [],
      "OutcomeDenomUnits": [],
      "OutcomeGroupDescription": [],
      "OutcomeGroupId": [],
      "OutcomeGroupTitle": [],
      "OutcomeMeasureAnticipatedPostingDate": [],
      "OutcomeMeasureCalculatePct": [],
      "OutcomeMeasureDenomUnitsSelected": [],
      "OutcomeMeasureDescription": [],
      "OutcomeMeasureDispersionType": [],
      "OutcomeMeasureParamType": [],
      "OutcomeMeasurePopulationDescription": [],
      "OutcomeMeasureReportingStatus": [],
      "OutcomeMeasureTimeFrame": [],
      "OutcomeMeasureTitle": [],
      "OutcomeMeasureType": [],
      "OutcomeMeasureTypeUnitsAnalyzed": [],
      "OutcomeMeasureUnitOfMeasure": [],
      "OutcomeMeasurementComment": [],
      "OutcomeMeasurementGroupId": [],
      "OutcomeMeasurementLowerLimit": [],
      "OutcomeMeasurementSpread": [],
      "OutcomeMeasurementUpperLimit": [],
      "OutcomeMeasurementValue": [],
      "OverallOfficialAffiliation": [],
      "OverallOfficialName": [],
      "OverallOfficialRole": [],
      "OverallStatus": [
            "Unknown status"
      ],
      "OversightHasDMC": [
            "No"
      ],
      "PatientRegistry": [],
      "Phase": [
            "Phase 2"
      ],
      "PointOfContactEMail": [],
      "PointOfContactOrganization": [],
      "PointOfContactPhone": [],
      "PointOfContactPhoneExt": [],
      "PointOfContactTitle": [],
      "PrimaryCompletionDate": [
            "December 31, 2019"
      ],
      "PrimaryCompletionDateType": [
            "Anticipated"
      ],
      "PrimaryOutcomeDescription": [
            "Pain on activity will be evaluated by VAS"
      ],
      "PrimaryOutcomeMeasure": [
            "Change from baseline in Visual Analog Scale(VAS) at 3, 6 and 12 weeks"
      ],
      "PrimaryOutcomeTimeFrame": [
            "Baseline, 3 weeks, 6 weeks, 12 weeks after intervention"
      ],
      "ReferenceCitation": [
            "Ellera Gomes JL, da Silva RC, Silla LM, Abreu MR, Pellanda R. Conventional rotator cuff repair complemented by the aid of mononuclear autologous stem cells. Knee Surg Sports Traumatol Arthrosc. 2012 Feb;20(2):373-7. doi: 10.1007/s00167-011-1607-9. Epub 2011 Jul 20.",
            "Pascual-Garrido C, Rol\u00f3n A, Makino A. Treatment of chronic patellar tendinopathy with autologous bone marrow stem cells: a 5-year-followup. Stem Cells Int. 2012;2012:953510. doi: 10.1155/2012/953510. Epub 2011 Dec 18.",
            "Hernigou P, Flouzat Lachaniette CH, Delambre J, Zilber S, Duffiet P, Chevallier N, Rouard H. Biologic augmentation of rotator cuff repair with mesenchymal stem cells during arthroscopy improves healing and prevents further tears: a case-controlled study. Int Orthop. 2014 Sep;38(9):1811-8. doi: 10.1007/s00264-014-2391-1. Epub 2014 Jun 7.",
            "Pas HIMFL, Moen MH, Haisma HJ, Winters M. No evidence for the use of stem cell therapy for tendon disorders: a systematic review. Br J Sports Med. 2017 Jul;51(13):996-1002. doi: 10.1136/bjsports-2016-096794. Epub 2017 Jan 11. Review.",
            "Lee SY, Kim W, Lim C, Chung SG. Treatment of Lateral Epicondylosis by Using Allogeneic Adipose-Derived Mesenchymal Stem Cells: A Pilot Study. Stem Cells. 2015 Oct;33(10):2995-3005. doi: 10.1002/stem.2110. Epub 2015 Aug 6.",
            "Ouyang HW, Goh JC, Thambyah A, Teoh SH, Lee EH. Knitted poly-lactide-co-glycolide scaffold loaded with bone marrow stromal cells in repair and regeneration of rabbit Achilles tendon. Tissue Eng. 2003 Jun;9(3):431-9.",
            "Minagawa H, Yamamoto N, Abe H, Fukuda M, Seki N, Kikuchi K, Kijima H, Itoi E. Prevalence of symptomatic and asymptomatic rotator cuff tears in the general population: From mass-screening in one village. J Orthop. 2013 Feb 26;10(1):8-12. doi: 10.1016/j.jor.2013.01.008. eCollection 2013."
      ],
      "ReferencePMID": [
            "21773831",
            "22220180",
            "24913770",
            "28077355",
            "26202898",
            "12857411",
            "24403741"
      ],
      "ReferenceType": [
            "background",
            "background",
            "background",
            "background",
            "background",
            "background",
            "background"
      ],
      "RemovedCountry": [],
      "ResponsiblePartyInvestigatorAffiliation": [],
      "ResponsiblePartyInvestigatorFullName": [],
      "ResponsiblePartyInvestigatorTitle": [],
      "ResponsiblePartyOldNameTitle": [],
      "ResponsiblePartyOldOrganization": [],
      "ResponsiblePartyType": [
            "Sponsor"
      ],
      "ResultsFirstPostDate": [],
      "ResultsFirstPostDateType": [],
      "ResultsFirstPostedQCCommentsDate": [],
      "ResultsFirstPostedQCCommentsDateType": [],
      "ResultsFirstSubmitDate": [],
      "ResultsFirstSubmitQCDate": [],
      "RetractionPMID": [],
      "RetractionSource": [],
      "SamplingMethod": [],
      "SecondaryId": [],
      "SecondaryIdDomain": [],
      "SecondaryIdLink": [],
      "SecondaryIdType": [],
      "SecondaryOutcomeDescription": [
            "Functional score of the shoulder",
            "Functional score of the shoulder",
            "Functional score of the shoulder",
            "Adverse events to evaluate the safety"
      ],
      "SecondaryOutcomeMeasure": [
            "Change from baseline in Constant-Murley Score(CMS) at 3, 6 and 12 weeks,",
            "American Shoulder and Elbow Surgeons (ASES) Shoulder Score",
            "The Disabilities of the Arm, Shoulder and Hand(DASH) Score",
            "Adverse events"
      ],
      "SecondaryOutcomeTimeFrame": [
            "Baseline, 3 weeks, 6 weeks, 12 weeks after intervention",
            "Baseline, 3 weeks, 6 weeks, 12 weeks after intervention",
            "Baseline, 3 weeks, 6 weeks, 12 weeks after intervention",
            "From baseline through study completion, an average of 1 year"
      ],
      "SeeAlsoLinkLabel": [],
      "SeeAlsoLinkURL": [],
      "SeriousEventAssessmentType": [],
      "SeriousEventNotes": [],
      "SeriousEventOrganSystem": [],
      "SeriousEventSourceVocabulary": [],
      "SeriousEventStatsGroupId": [],
      "SeriousEventStatsNumAffected": [],
      "SeriousEventStatsNumAtRisk": [],
      "SeriousEventStatsNumEvents": [],
      "SeriousEventTerm": [],
      "StartDate": [
            "October 1, 2018"
      ],
      "StartDateType": [
            "Anticipated"
      ],
      "StatusVerifiedDate": [
            "August 2017"
      ],
      "StdAge": [
            "Adult",
            "Older Adult"
      ],
      "StudyFirstPostDate": [
            "September 12, 2017"
      ],
      "StudyFirstPostDateType": [
            "Actual"
      ],
      "StudyFirstSubmitDate": [
            "September 4, 2017"
      ],
      "StudyFirstSubmitQCDate": [
            "September 10, 2017"
      ],
      "StudyPopulation": [],
      "StudyType": [
            "Interventional"
      ],
      "SubmissionMCPReleaseN": [],
      "SubmissionReleaseDate": [],
      "SubmissionResetDate": [],
      "SubmissionUnreleaseDate": [],
      "TargetDuration": [],
      "UnpostedEventDate": [],
      "UnpostedEventType": [],
      "UnpostedResponsibleParty": [],
      "VersionHolder": [
            "October 10, 2022"
      ],
      "WhyStopped": []
}